Opinion: Ocrevus takes a step forward in treating multiple sclerosis
By K. Leelamoni March 18, 2024: Akhila came up with a surprise statement while I was talking to her. “Mam’ I have multiple.
Drugs
Health
Pharma
Climate
Health
Pharma
Environment, lifestyle behind epidemic of autoimmune diseases
HQ Team November 28, 2023: An escalating global crisis is unfolding as an increasing number of individuals grapple with autoimmune diseases, conditions wherein.
Drugs
Health
Pharma
USFDA green lights Sandoz’s biosimilar Tyruko to treat multiple sclerosis
HQ Team August 25, 2023: The US drug regulator gave its nod for Sandoz Inc., an arm of Sweden-based Novartis and which is.
Drugs
Health
Pharma
Vaccine to treat Epstein-Brarr virus developed in mice
HQ Team August 17, 2023: A study on mice has produced a vaccine for Epstein-Barr virus, which is linked to a 32-fold higher.
Drugs
Health
Pharma
Cancer, multiple sclerosis, Ebola treatments in new WHO Essential Medicines List
HQ Team July 26, 2023: Medicines for treating diseases such as cancer, multiple sclerosis, cardiovascular conditions, Ebola, and diabetes have been added to.
Drugs
Health
Pharma
Gene variant discovery may trigger new treatments for multiple sclerosis
HQ Team July 5, 2023: Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way.
Drugs
Health
Pharma
FDA applies brakes on Merck’s multiple sclerosis drug tests
HQ Team April 13, 2023: Merck KGaA announced the USFDA had put a hold on the initiation of new patients to test its.
Drugs
Pharma
Israeli firm Teva Pharmaceuticals under EC scanner
The EC has intimated Teva Pharmaceutical Industries, an Israel-based global company, of its "preliminary view" that it has breached EU antitrust rules by.